fashion -WSS

fashion

author：fashion 2025-09-28 15:57:09 - browse：7

Red blood cells flow in an artery biotech — coverage from STAT — Adobe

PHILADELPHIA — An investigational drug aimed at preventing strokes significantly reduced the risk of bleeding compared with a commonly used blood thinner for stroke prevention, showing potential to be a safer alternative for patients.

Among patients with atrial fibrillation, an abnormal heart rhythm that increases the risk of stroke, abelacimab, developed by Anthos Therapeutics, cut the overall risk of bleeding by 67% compared to rivaroxaban, the blood thinner sold as Xarelto by Janssen Pharmaceuticals.

The treatment, injected monthly, also reduced the risk of major bleeding events by 74% and gastrointestinal bleeding by 93%, according to Phase 2 results presented here Sunday at the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： How Long Island became the ‘eugenics capital of the world’

WSS

Publishing genetic code of viruses could cause disaster

Experimental asthma app from Apple and Anthem shows promise

Ventyx halts psoriasis drug development after lackluster trial results

Complete sequence of Y chromosome published for first time

Study finds new variant for Parkinson’s in African populations

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

Wikipedia

fashion

focus

Sports medicine is finally prioritizing gender equality

Cancer diagnosis changes perspective doctor, former hospital CEO

Activists slam private health insurers over coverage restrictions

Winners, losers from Medicare’s list of drugs subject to price talks

ChatGPT in medicine: STAT answers readers' burning questions

How to make Best Hospitals ratings actually useful for patients

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Type 2 diabetes prevention programs work at large scale: study

What does generative AI mean for health care? We asked experts

What is STAT's opinion section for?

entertainment

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

Type 2 diabetes prevention programs work at large scale: study

Ventyx halts psoriasis drug development after lackluster trial results

NYU Langone launches private ChatGPT for its health care data

Departing Stanford president retracts two papers

After decades in use, heart stents finally beat placebo

explore

focus

knowledge

hotspot